COVID-19 VLP (S; Luciferase)(CBS-V927)
Inquiry
| Product Summary | |
|---|---|
| Name | COVID-19 VLP (S; Luciferase) |
Download Datasheet
|
|
| Cat No. | CBS-V927 |
| Source | Pseudotyped lentivirus |
| Virus Name | SARS-CoV-2 |
| Virus Family | Coronaviridae |
| Composition | S-his, Luciferase |
| Purity | 90% |
| Presentation | PBS |
| Description | It is the replication-incompetent particles in which the native, full-length COVID-19 S protein (with 6His-tag at its C-terminal) was pseudo-typed as the lentiviral particles’ surface envelope protein. The virus genome is not included. Instead it was replaced by a Luciferase under CMV promoter. It is mock lentivirus.This VLP binds to cells that express any S-protein binding receptor, like ACE2. When this binding occur, the VLP stay at surface of the cells and also can get into cells, then the luciferase signal can be detected. |
For Research or Industrial Raw Materials, Not for Personal Use!
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frequently Asked Questions
-
What expression systems do you use for your VLP products?
Our virus-like particles are produced from different expression systems such as E. coli, yeast, insect cells, and HEK293 cells.
